Cognitive impairment in community-dwelling older Nigerians: Clinical correlates and stability of diagnosis

European Journal of Neurology

Volumn 9, Issue 6, 2002, Pages 573-580

  Baiyewu, O ^a,d   Unverzagt, F W ^b   Ogunniyi, A ^a   Hall, K S ^b   Gureje, O ^a   Gao, S ^b   Lane, K A ^b   Hendrie, H C ^b,c  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY CENTER FOR AGING RESEARCH   (United States)

^d UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Cognitive impairment; Nigerians

Indexed keywords

APOLIPOPROTEIN;

AGED; ARTICLE; COGNITIVE DEFECT; COMMUNITY MEDICINE; DEMENTIA; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGERIA; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; PSYCHOLOGICAL ASPECT;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DEMENTIA; FEMALE; HUMANS; MALE; NIGERIA;

EID: 0036835958     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2002.00434.x     Document Type: Article

References (36)

1. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, Rev. American Psychiatric Association, Washington, DC.
2. Blessed G, Tomlinson BE, Roth M (1968). The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry 114:797-811.
3. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB (1997). Progression to dementia in patients with isolated memory loss. Lancet 349:763-765.
4. Chandra V, Ganguli M, Pandav R, Johnston J, Belle S, DeKosky ST (1998). Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study. Neurology 51:1000-1008.
5. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S (1986). Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change - report of a National Institute of Mental Health Work Group. Dev Neurol 2:261-276.
6. Ebly EM, Hogan DB, Parhad IM (1995). Cognitive impairment in the nondemented elderly: results from the Canadian Study of Health and Aging. Arch Neurol 52:612-619.
7. Farrag AKF, Farwiz HM, Kheds EH, Mahfouz RM, Omran SM (1998). Prevalence of Alzheimer's disease and other dementing disorders: Assiut-Upper Egypt Study. Dement Geriatr Cogn Disord 9:323-328.
8. Flicker C, Ferris SH, Reisberg B (1991). Mild cognitive impairment in the elderly: predictors of dementia. Neurology 41:1006-1009.
9. Graham JE, Rockwood K, Beattie BL et al. (1997). Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349:1793-1796.
10. Gureje O, Unverzagt FW, Osuntokun BO et al. (1995). The CERAD neuropsychological test battery: norms from a Yoruba-speaking Nigerian sample. West Afr J Med 14:29-33.
11. Gurland BJ, Copeland JRM, Kuriansky J, Kelleher A, Sharpe L, Dean LL (1982). The Mind and Mood of Aging Mental Problems of the Community Elderly in New York and London. Croom-Helm Ltd., Totowa, NJ.
12. Hall KS, Hendrie HC, Rodgers DD, Osuntokun BO, Postl BD (1993). The development of a dementia screening interview in two distinct languages. Int J Methods Psychiatr Res 3:1-28.
13. Hall KS, Ogunniyi AO, Hendrie HC et al. (1996). A cross-cultural community based study of dementias: methods and performance of the survey instrument, Indianapolis, USA, and Ibadan, Nigeria. Int J Methods Psychiatr Res 6:129-142.
14. Hendrie HC (1998). Epidemiology of dementia and alzheimer's disease. Am J Geriatr Psychiatry 6:S3-S18.
15. Hendrie HC, Ogunniyi A, Hall KS et al. (2001). Incidence of dementia and Alzheimer disease in two communities: Yoruba residing in Ibadan, Nigeria and African Americans residing in Indianapolis, USA. J Am Med Assoc 285:739-747.
16. Hendrie HC, Osuntokun BO, Hall KS et al. (1995). Prevalence of Alzheimer's Disease and Dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 152:1485-1492.
17. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982). A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572.
18. Kaufman JS, Rotimi CN, Brieger WR et al. (1996). The mortality risk associated with hypertension: preliminary results of a prospective study in rural Nigeria. J Hum Hypertens 10:461-464.
19. Kral VA (1962). Senescent forgetfulness: benign and malignant. Can Med Assoc J 86:257-276.
20. Levy RC, Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization (1994). Report: aging-associated cognitive decline. Int Psychogeriatr 6:63-68.
21. Li G, Shen YC, Chen CH, Zhao YW, Li SR, Lu M (1989). An epidemiological survey of age-related dementia in an urban area of Beijing. Acta Psychiatr Scand 79:557-563.
22. Morris JC, Heyman A, Mohs RC et al. (1989). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Part I: clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39:1159-1165.
23. Morris JC, Storandt M, Miller P et al. (2001). Mild cognitive impairment represents early stage Alzheimer Disease. Archieves of Neurology 58:397-405.
24. O'Connor DW, Pollitt PA, Hyde JB, Fellows JL, Miller ND, Roth M (1990). A follow-up study of dementia diagnosed in the community using the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand 81:78-82.
25. Ogunniyi A, Osuntokun BO (1993). Determination of ages of elderly Nigerians through historical events: validation of Ajayi-Igun 1963 listing. West Afr J Med 12:189-190.
26. Osuntokun BO, Sahota A, Ogunniyi AO et al. Association between the e4 allele of Apolipoprotein E and Alzheimers disease in elderly Nigerians. Ann Neurol 38:463-465.
27. Petersen RC, Smith GE, Ivnik RJ et al. (1995). Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. J Am Med Assoc 273:1274-1278.
28. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999). Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303-308.
29. Ritchie K, Touchon J (2000). Mild cognitive impairment: conceptual basis and current nosological status. Lancet 355:225-228.
30. Roth M, Tym E, Mountjoy CO et al. (1986). CAMDEX: A standardized instrument for the diagnosis of mental disorders in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698-709.
31. Rubin EH, Morris JC, Grant EA, Vendegna T (1989). Very mild senile dementia of the Alzheimer type I. Clinical assessment. Arch Neurol 46:379-382.
32. Tierney MC, Szalai JP, Snow WG, Fisher RH (1996). The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits. Arch Neurol 53:423-427.
33. Unverzagt FW, Gao S, Baiyewu O et al. (2001). Prevalence of cognitive impairment: data from the Indianapolis study of health and aging. Neurology 57:1655-1692.
34. World Health Organization (1992). Mental behavioral and developmental disorders, clinical descriptions and diagnostic guidelines. In: International and Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). World Health Organization, Geneva, pp. F00-F99 (Categories).
35. Zaudig M (1992). A new systematic method of measurement and diagnosis of 'mild cognitive impairment' and dementia according to ICD-10 and DSM-III-R criteria. Int Psychogeriatr 4 (Suppl. 2): 203-219.
36. Zhang M, Katzman R, Salmon D et al. (1990). The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 27:428-437.